BALTIMORE, M.D. — CMS announced Dec. 14 it will recommend coverage for home-based sleep testing for obstructive sleep apnea. The Medicare Evidence Development and Coverage Advisory Committee recommended that coverage be expanded to cover treatment for patients with a clinical evaluation and an unattended home sleep study using a type 11, 111 or IV device and that CPAP coverage initially be limited to 12 weeks.
Comments